I couldn't get that last link to work so I will post the abstract in its entirety. The salient point is this has nothing to do with isomers of ALA. It is the basic prooxidant property of ALA that is responsible for its enhancement of glucose uptake in diabetic individuals, as well as its negative effects on glycogen synthase:
Toxicol Appl Pharmacol 2002 Jul 1;182(1):84-90 Related Articles, Links
Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid.
Moini H, Packer L, Saris NE.
Department of Applied Chemistry and Microbiology, PB 56 Viikki Biocenter, FIN-00014, University of Helsinki, Helsinki, Finland.
[email protected]
Reactive oxygen (ROS) and nitrogen oxide (RNOS) species are produced as by-products of oxidative metabolism. A major function for ROS and RNOS is immunological host defense. Recent evidence indicate that ROS and RNOS may also function as signaling molecules. However, high levels of ROS and RNOS have been considered to potentially damage cellular macromolecules and have been implicated in the pathogenesis and progression of various chronic diseases. alpha-Lipoic acid and dihydrolipoic acid exhibit direct free radical scavenging properties and as a redox couple, with a low redox potential of -0.32 V, is a strong reductant. Several studies provided evidence that alpha-lipoic acid supplementation decreases oxidative stress and restores reduced levels of other antioxidants in vivo. However, there is also evidence indicating that alpha-lipoic acid and dihydrolipoic acid may exert prooxidant properties in vitro. alpha-Lipoic acid and dihydrolipoic acid were shown to promote the mitochondrial permeability transition in permeabilized hepatocytes and isolated rat liver mitochondria. Dihydrolipoic acid also stimulated superoxide anion production in rat liver mitochondria and submitochondrial particles.
alpha-Lipoic acid was recently shown to stimulate glucose uptake into 3T3-L1 adipocytes by increasing intracellular oxidant levels and/or facilitating insulin receptor autophosphorylation presumably by oxidation of critical thiol groups present in the insulin receptor beta-subunit. Whether alpha-lipoic acid and/or dihydrolipoic acid-induced oxidative protein modifications contribute to their versatile effects observed in vivo warrants further investigation.
Likewise, in the previous abstract posted by JGUNS.
"These data show that in this model, LA acts as a mild prooxidant, causing mitochondrial uncoupling and inhibition of glycogen synthesis."
So you ALA advocates can't have your cake and eat it too. If you accept that ALA enhances glucose transport, then the evidence points to the same mechanism being responsible for inhibition of glycogen synthase.
As Ulter knows, I have been cautioning people against ALA from day one. I have no vested interest in any competing product. This is not about having a financial stake in a product as far as I am concerned. It is about providing the most up to date information possible about supplements.